242 related articles for article (PubMed ID: 15743470)
21. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium.
Patel DD; Zachariah JP; Whichard LP
Clin Immunol; 2001 Jan; 98(1):39-45. PubMed ID: 11141325
[TBL] [Abstract][Full Text] [Related]
22. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis.
Shin JJ; Glickstein LJ; Steere AC
Arthritis Rheum; 2007 Apr; 56(4):1325-35. PubMed ID: 17393419
[TBL] [Abstract][Full Text] [Related]
23. Comparison of blood and synovial fluid th17 and novel peptidase inhibitor 16 Treg cell subsets in juvenile idiopathic arthritis.
Grose RH; Millard DJ; Mavrangelos C; Barry SC; Zola H; Nicholson IC; Cham WT; Boros CA; Krumbiegel D
J Rheumatol; 2012 Oct; 39(10):2021-31. PubMed ID: 22896021
[TBL] [Abstract][Full Text] [Related]
24. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis.
Cosmi L; Cimaz R; Maggi L; Santarlasci V; Capone M; Borriello F; Frosali F; Querci V; Simonini G; Barra G; Piccinni MP; Liotta F; De Palma R; Maggi E; Romagnani S; Annunziato F
Arthritis Rheum; 2011 Aug; 63(8):2504-15. PubMed ID: 21381000
[TBL] [Abstract][Full Text] [Related]
25. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
[TBL] [Abstract][Full Text] [Related]
26. Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation.
Nagpal ML; Chen Y; Lin T
J Endocrinol; 2004 Dec; 183(3):585-94. PubMed ID: 15590984
[TBL] [Abstract][Full Text] [Related]
27. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
[TBL] [Abstract][Full Text] [Related]
28. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
Soejima K; Rollins BJ
J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
[TBL] [Abstract][Full Text] [Related]
29. The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands.
Ospelt C; Kurowska-Stolarska M; Neidhart M; Michel BA; Gay RE; Laufer S; Gay S
Ann Rheum Dis; 2008 Apr; 67(4):524-9. PubMed ID: 17666446
[TBL] [Abstract][Full Text] [Related]
30. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
[TBL] [Abstract][Full Text] [Related]
31. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J
Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283
[TBL] [Abstract][Full Text] [Related]
32. Expression of CXC chemokine IP-10 in testicular germ cell tumours.
Schweyer S; Soruri A; Baumhoer D; Peters J; Cattaruzza M; Radzun HJ; Fayyazi A
J Pathol; 2002 May; 197(1):89-97. PubMed ID: 12081209
[TBL] [Abstract][Full Text] [Related]
33. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.
Trentin L; Agostini C; Facco M; Piazza F; Perin A; Siviero M; Gurrieri C; Galvan S; Adami F; Zambello R; Semenzato G
J Clin Invest; 1999 Jul; 104(1):115-21. PubMed ID: 10393705
[TBL] [Abstract][Full Text] [Related]
34. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
[TBL] [Abstract][Full Text] [Related]
35. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
36. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
Schlenk J; Lorenz HM; Haas JP; Herrmann M; Hohenberger G; Kalden JR; Röllinghoff M; Beuscher HU
J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752
[TBL] [Abstract][Full Text] [Related]
37. Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation.
Ebert LM; McColl SR
J Immunol; 2001 Apr; 166(8):4870-8. PubMed ID: 11290763
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.
Agostini C; Cassatella M; Zambello R; Trentin L; Gasperini S; Perin A; Piazza F; Siviero M; Facco M; Dziejman M; Chilosi M; Qin S; Luster AD; Semenzato G
J Immunol; 1998 Dec; 161(11):6413-20. PubMed ID: 9834133
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
40. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
